Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-26

Clinical Trial Update: Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating velusetrag for diabetic and idiopathic gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Velusetrag (Velusetrag)

Snippet

Sponsor: Theravance Biopharma | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED